Marianne Koritzinsky

Researcher
  • Princess Margaret Cancer Centre
  • University Health Network
  • University of Toronto
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Multiple Cancers

    Triggers and Targets in the Tumour Microenvironment: Hypoxia and Beyond

    A leading team of scientists at Toronto’s Princess Margaret Cancer Centre is set to expand its groundbreaking research into the effects of low oxygen levels (hypoxia) on tumour aggressiveness th...

    Read More
  • All Cancers

    STARS21: Strategic training in transdisciplinary radiation science for the 21st century

    Today, radiation is used to diagnose and treat many medical conditions, including most cancers. This radiation, which can take several forms, plays a role in everything from imaging to therapy, and is...

    Read More
  • Completed
    Multiple Cancers

    Research pipeline for hypoxia-directed precision cancer medicine

    A new approach for a long-time funded Terry Fox research program has leaders of the initiative excited about personalizing treatment for cancer patients by bringing together two areas of study: genomi...

    Read More
  • Completed
    All Cancers

    The impact of hypoxia on the maturation of extracellular proteins that regulate tumour metabolism and microenvironment

    Dr. Marianne Koritzinsky, University of Toronto assistant professor with academic appointments in the University of Toronto’s Department of Radiation Oncology and Institute of Medical Science, h...

    Read More

Related News & Events

  • Press Release|July 04, 2019

    Two top Canadian research teams receive $12 million to solve key cancer challenges

    The teams, which are based in Toronto and Montreal/Ottawa, will use the funding to dive deep into the unique biology of cancer cells with the hopes of...

  • Press Release|July 03, 2019

    Trouver dans le microenvironnement des tumeurs de nouvelles cibles thérapeutiques en vue de personnaliser les traitements contre le cancer

    Une équipe de spécialistes chevronnés du Princess Margaret Cancer Centre de Toronto est appelée à élargir ses travaux de recherche novateurs sur les e...

  • Research Highlight|May 01, 2018

    Canadian leaders in tumour hypoxia shed light on the role of mTOR signalling in prostate cancer development

    More findings from TFRI’s prestigious hypoxia team are continuing to change the cancer research landscape when it comes to understanding the role of t...

  • Research Highlight|May 24, 2017

    MATE2 expression a negative predictive biomarker to metformin’s efficacy in cancer treatment, study suggests

    The drug metformin is typically used to treat Type 2 diabetes, and some cancer patients have shown improved outcome when given the drug. A recent stud...

  • TFRI News|July 09, 2012

    2011 New Investigator awardees receive $1.7 million

    2011 New Investigator awardees receive $1.7 million

  • All News & Events